Inhibitory effects of NK cells were detected in OSCC in peripheral blood and tumor tissue, with increased expression of suppressive cytokines interleukine-10 (IL-10) and tumor growth factor-β (TGF-β) and decreased expression of activating receptor NKp46 [50]. The gene discussed is TGFB1; the disease is neoplasm.